Echo Therapeutics (ECTE) announces a secondary offering, but no details of the size or terms were given. Aegis Capital is acting as the sole book-running manager for the offering. Shares -7.8% AH.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs